Skip Navigation LinksHome > July 2014 - Volume 33 - Issue 7 > Clinical Evaluation of Vancomycin Dosage in Pediatric Oncolo...
Pediatric Infectious Disease Journal:
doi: 10.1097/INF.0000000000000268
Antimicrobial Reports

Clinical Evaluation of Vancomycin Dosage in Pediatric Oncology Patients

Sanders, Stefan J.W.J. PharmD*; Bijleveld, Yuma A. PharmD*; Sinkeler, Fleur BSc*; Kemper, Elles M. PharmD, PhD*; Pajkrt, Dasja MD, PhD, MBA; van de Wetering, Marianne MD, PhD; van Eijkelenburg, Natasha K.A. MD; Mathôt, Ron A.A. PharmD, PhD*

Collapse Box


Vancomycin trough serum concentrations were below therapeutic range (8–15 mg/L) in 58% of 124 pediatric oncology patients receiving 60 mg/kg/d divided qid. Patients <6 and between 6 and 12 years had significantly lower trough concentrations than patients >12 years. A vancomycin dosage of 60 mg/kg/d is inadequate for pediatric oncology patients >12 years.

© 2014 by Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.